SCHEMBL7778634

SCHEMBL7778634

Cc1cccc(Nc2cc(Nc3ccc(OCC(=O)NCCO)cc3)ncn2)c1

nearest known ligand 0.61

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
EGFR P00533 5/20 0.61
ALDH1A1 P00352 1/20 0.50
MAPK1 P28482 1/20 0.49
HTT P42858 1/20 0.48
ERBB3 P21860 3/20 0.48
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
RAB9A P51151 3/20 0.47
NPC1 O15118 2/20 0.47
POLB P06746 1/20 0.47
ABL1 P00519 1/20 0.46
BCR P11274 1/20 0.46
PPARD Q03181 1/20 0.46
TNNI3K Q59H18 1/20 0.46
NPY1R P25929 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1387354 0.89 EGFR (0.50) EGFRALDH1A1MAPK1HTTERBB3
SCHEMBL7771239 0.87 EGFR (0.54) EGFRMAPK1HTTERBB3MEN1
SCHEMBL7777399 0.84 EGFR (0.55) EGFRMAPK1HTTERBB3MEN1
SCHEMBL8318193 0.82 EGFR (0.55) EGFRMAPK1HTTERBB3MEN1
SCHEMBL1387422 0.82 EGFR (0.65) EGFRERBB3MEN1KMT2ARAB9A
SCHEMBL8320776 0.82 EGFR (0.53) EGFRMAPK1HTTERBB3MEN1
SCHEMBL7776054 0.82 EGFR (0.58) EGFRMAPK1HTTERBB3MEN1
SCHEMBL7778617 0.81 EGFR (0.64) EGFRERBB3MEN1KMT2ARAB9A
SCHEMBL7775654 0.80 ALDH1A1 (0.52) EGFRALDH1A1ERBB3MEN1KMT2A
SCHEMBL7771258 0.79 EGFR (0.55) EGFRMAPK1HTTERBB3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0733045-B1 4,6-DIANILINO-PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TYROSINE KINASE INHIBITORS ASTRAZENECA AB (SE) 2001-08-16 EP disclosed
US-5880130-A TREATMENT OF CELL-PROLIFERATION DISEASES ZENECA LIMITED (GB) 1999-03-09 US disclosed